Clinical Trial

Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

Recruiting
View on ClinicalTrials.gov →
Summary
From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022. A review will be made from the medical records, radiological imaging, and histological data of these patients
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-23; most recent amendment 2025-12-12.
Status change: Not Yet Recruiting → Recruiting 2024-12-13
Trial Details
NCT Number NCT06524843
Lead Sponsor Costantino Errani
Conditions Bone Metastases
Enrollment 250 participants
Start Date 2024-09-23
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-15